Taurine and tauroursodeoxycholic acid are used for treating cerebral ischemia. In this study, we used the combination of taurine and tauroursodeoxycholic acid to establish a model of ischemia-reperfusion injury and evaluate the effect and target of the drug combination using the neurovascular unit (NVU) model of hypoxia and reoxygenation in vitro. Results showed that the combined application of these two drugs improved the survival of neurons, astrocytes, and endothelial cells; reduced inflammatory damage, levels of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-1β, oxidative stress response, and the release of malondialdehyde and nitric oxide; and enhanced the activity of superoxide dismutase. Simultaneously, they acted on the blood–brain barrier (BBB) and improved the transendothelial electrical resistance value, reduced lactate dehydrogenase levels, improved the activity of γ-glutamyl transferase, and protected the integrity of the BBB against damage caused by oxygen-glucose deprivation/reoxygenation. At the same time, they prevented neuronal apoptosis, reduced the expression of Bax and caspase-3, and increased the expression of Bcl-2. These two drugs regulated the expression of connexin 43 (CX43) and aquaporin 4 (AQP4) in astrocytes, reducing the level of AQP4, and improving the activity of CX43. In addition, the drug combination increased the expression of tight junction proteins in endothelial cells, such as zona occludens-1, occluding, and claudin-5, and decreased the expression of matrix metalloproteinase (MMP)2 and MMP9. Furthermore, they acted together on the p38 mitogen-activated protein kinase (MAPK) signaling pathway, and the addition of the p38 inhibitor SB203580 partially inhibited the expression of p38MAPK. Thus, the combined action of these drugs protected the NVU.
ZhaoY, ZhangX, ChenX, et al.Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment. Int J Mol Med, 2022; 49(2):15–19.
2.
ShiK, ZouM, JiaDM, et al.tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke. Circ Res, 2021; 128(1):62–75.
3.
RafieeZ, García-SerranoAM, DuarteJMN. Taurine supplementation as a neuroprotective strategy upon brain dysfunction in metabolic syndrome and diabetes. Nutrients, 2022; 14(6):1292.
4.
SeolSI, KimHJ, ChoiEB, et al.Taurine protects against postischemic brain injury via the antioxidant activity of taurine chloramine. Antioxidants (Basel), 2021; 10(3):372.
5.
JangraA, GolaP, SinghJ, et al.Emergence of taurine as a therapeutic agent for neurological disorders. Neural Regen Res, 2024; 19(1):62–68.
6.
WangL, XieZ, WuM, et al.The role of taurine through endoplasmic reticulum in physiology and pathology. Biochem Pharmacol, 2024; 226:116386.
7.
JakariaM, AzamS, HaqueME, et al.Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biol, 2019; 24:101223.
8.
ZhangZ, ZhaoL, ZhouY, et al.Taurine ameliorated homocysteine-induced H9C2 cardiomyocyte apoptosis by modulating endoplasmic reticulum stress. Apoptosis, 2017; 22(5):647–661.
9.
GharibaniP, ModiJ, MenzieJ, et al.Comparison between single and combined post-treatment with S-Methyl-N, N-diethylthiolcarbamate sulfoxide and taurine following transient focal cerebral ischemia in rat brain. Neuroscience, 2015; 300:460–473.
10.
ZhangZ, YuR, CaoL. Neuroprotection of taurine through inhibition of 12/15 lipoxygenase pathway in cerebral ischemia of rats. Neurol Res, 2017; 39(5):453–458.
11.
ZangerolamoL, VettorazziJF, RosaLRO, et al.The bile acid TUDCA and neurodegenerative disorders: An overview. Life Sci, 2021; 272:119252.
12.
GronbeckKR, RodriguesCMP, MahmoudiJ, et al.Application of tauroursodeoxycholic acid for treatment of neurological and non-neurological diseases: Is there a potential for treating traumatic brain injury? Neurocrit Care, 2016; 25(1):153–166.
13.
Yanguas‐CasásN, Barreda‐MansoMA, Nieto‐SampedroM, et al.TUDCA: An agonist of the bile acid receptor GPBAR1/TGR5 with anti‐inflammatory effects in microglial cells. Journal Cellular Physiology, 2017; 232(8):2231–2245.
14.
ChenF, GeZ, LiN, et al.TUDCA protects against tunicamycin-induced apoptosis of dorsal root ganglion neurons by suppressing activation of ER stress. Exp Ther Med, 2022; 24(2):509.
15.
DuanXC, WangW, FengDX, et al.Roles of autophagy and endoplasmic reticulum stress in intracerebral hemorrhage‐induced secondary brain injury in rats. CNS Neurosci Ther, 2017; 23(7):554–566.
16.
DaruichA, PicardE, GuéganJ, et al.Comparative analysis of Urso-and tauroursodeoxycholic acid neuroprotective effects on retinal degeneration models. Pharmaceuticals (Basel), 2022; 15(3):334.
17.
IrieT, MatsudaT, HayashiY, et al.Direct neuronal conversion of microglia/macrophages reinstates neurological function after stroke. Proc Natl Acad Sci U S A, 2023; 120(42):e2307972120.
18.
WangL, XiongX, ZhangL, et al.Neurovascular Unit: A critical role in ischemic stroke. CNS Neurosci Ther, 2021; 27(1):7–16.
19.
LiC, SuiC, WangW, et al.Baicalin attenuates oxygen–glucose deprivation/reoxygenation–induced injury by modulating the BDNF-TrkB/PI3K/Akt and MAPK/Erk1/2 signaling axes in neuron–astrocyte cocultures. Front Pharmacol, 2021; 12:599543.
20.
LiC, WangX, ChengF, et al.Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system. Eur J Pharmacol, 2019; 854:224–231.
21.
LiC-X, WangX-Q, ChengF-F, YanX, LuoJ, WangQ-G. Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury in vitro. Neural Regen Res, 2019; 14(11):1941–1949.
22.
MenzieJ, PrenticeH, WuJ-Y. Neuroprotective mechanisms of taurine against ischemic stroke. Brain Sci, 2013; 3(2):877–907.
23.
MersmanB, ZaidiW, SyedNI, XuF. Taurine promotes neurite outgrowth and synapse development of both vertebrate and invertebrate central neurons. Front Synaptic Neurosci, 2020; 12:29.
24.
ShaoA, HathcockJN. Risk assessment for the amino acids taurine, L-glutamine and L-arginine. Regul Toxicol Pharmacol, 2008; 50(3):376–399.
25.
MaH, ZengM, HanY, et al.A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis. Medicine (Baltimore), 2016; 95(47):e5391.
26.
PanX-L, ZhaoL, LiL, et al.Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: A double-blind randomized controlled trial. J Huazhong Univ Sci Technol [Med Sci], 2013; 33(2):189–194.
27.
EliaAE, LalliS, MonsurròMR, et al.Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. Eur J Neurol, 2016; 23(1):45–52.
28.
SchmidR, SieghartW, KarobathM. Taurine uptake in synaptosomal fractions of rat cerebral cortex. J Neurochem, 1975; 25(1):5–9.
29.
AhmadianM, RoshanVD, AslaniE, StannardSR. Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failure. Ther Adv Cardiovasc Dis, 2017; 11(7):185–194.
30.
Yanguas-CasasN, Barreda-MansoMA, Nieto-SampedroM, Romero-RamirezL. Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation. J Neuroinflammation, 2014; 11(1):50.
31.
Yanguas-CasasN, Barreda-MansoMA, Perez-RialS, Nieto-SampedroM, Romero-RamirezL. TGFbeta contributes to the anti-inflammatory Effects of Tauroursodeoxycholic Acid on an animal model of Acute Neuroinflammation. Mol Neurobiol, 2017; 54(9):6737–6749.
32.
WuX, LiuC, ChenL, et al.Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice. Int Immunopharmacol, 2019; 72:166–175.
33.
SongS, HuangH, GuanX, et al.Activation of endothelial Wnt/β-catenin signaling by protective astrocytes repairs BBB damage in ischemic stroke. Prog Neurobiol, 2021; 199:101963.
34.
SchaefferS, IadecolaC. Revisiting the neurovascular unit. Nat Neurosci, 2021; 24(9):1198–1209.
35.
TiedtS, BuchanAM, DichgansM, et al.The neurovascular unit and systemic biology in stroke—Implications for translation and treatment. Nat Rev Neurol, 2022; 18(10):597–612.
36.
KimY, ChoAY, KimHC, et al.Effects of natural polyphenols on oxidative stress-mediated blood-brain barrier dysfunction. Antioxidants (Basel), 2022; 11(2):197.
37.
YiX, XuC, HuangP, et al.1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) urea protects the blood-brain barrier against ischemic injury by upregulating tight junction protein expression, mitigating apoptosis and inflammation in vivo and in vitro model. Front Pharmacol, 2020; 11:1197.
38.
MaoM, CaoX, LiangY, et al.Neuroprotection of rhubarb extract against cerebral ischaemia-reperfusion injury via the gut-brain axis pathway. Phytomedicine, 2024; 126:155254.
39.
WeiX, WenY, HuY, et al.Total Saponins of Panax notoginseng modulate the astrocyte inflammatory signaling pathway and attenuate inflammatory injury induced by oxygen-glucose deprivation/reperfusion injury in rat brain microvascular endothelial cells. CSCR, 2024; 19(2):267–276.
40.
MoujalledD, StrasserA, LiddellJR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ, 2021; 28(7):2029–2044.
41.
LiZ, XiaoG, WangH, et al.A preparation of Ginkgo biloba L. leaves extract inhibits the apoptosis of hippocampal neurons in post-stroke mice via regulating the expression of Bax/Bcl-2 and Caspase-3. J Ethnopharmacol, 2021; 280:114481.
42.
PengT, LiS, LiuL, et al.Artemisinin attenuated ischemic stroke induced cell apoptosis through activation of ERK1/2/CREB/BCL-2 signaling pathway in vitro and in vivo. Int J Biol Sci, 2022; 18(11):4578–4594.
43.
StokumJA, ShimB, NegoitaS, et al.Cation flux through SUR1-TRPM4 and NCX1 in astrocyte endfeet induces water influx through AQP4 and brain swelling after ischemic stroke. Sci Signal, 2023; 16(788):eadd6364.
44.
ChenYY, GongZC, ZhangMM, et al.Brain-targeting emodin mitigates ischemic stroke via inhibiting AQP4-mediated swelling and neuroinflammation. Transl Stroke Res, 2024; 15(4):818–830.
45.
ChuH, DongJ, TangY, et al.Connexin 43 promotes neurogenesis via regulating aquaporin-4 after cerebral ischemia. Neurotox Res, 2023; 41(4):349–361.
46.
FengX, LiM, LinZ, et al.Tetramethylpyrazine promotes stroke recovery by inducing the restoration of neurovascular unit and transformation of A1/A2 reactive astrocytes. Front Cell Neurosci, 2023; 17:1125412.
47.
CibelliA, StoutR, TimmermannA, et al.Cx43 carboxyl terminal domain determines AQP4 and Cx30 endfoot organization and blood brain barrier permeability. Sci Rep, 2021; 11(1):24334.
48.
LiuY, ChenL, LinL, et al.Unveiling the hidden pathways: Exploring astrocytes as a key target for depression therapy. J Psychiatr Res, 2024; 174:101–113.
49.
LiangZ, LouY, HaoY, et al.The relationship of astrocytes and microglia with different stages of ischemic stroke. Curr Neuropharmacol, 2023; 21(12):2465–2480.
50.
BretováK, SvobodováV, DubovýP. Changes in Cx43 and AQP4 proteins, and the capture of 3 kDa dextran in subpial astrocytes of the rat medial prefrontal cortex after both sham surgery and sciatic nerve injury. Int J Mol Sci, 2024; 25(20):10989.
51.
GuoM, QuS, LuH, et al.Biochanin A alleviates cerebral ischemia/reperfusion injury by suppressing endoplasmic reticulum stress-induced apoptosis and p38MAPK signaling pathway in vivo and in vitro. Front Endocrinol (Lausanne), 2021; 12:646720.
52.
ChenW, WuZ, YinM, et al.Blockage of p38MAPK in astrocytes alleviates brain damage in a mouse model of embolic stroke through the CX43/AQP4 axis. J Stroke Cerebrovascular Dis, 2024; 33(12):108085.
53.
XieQ, LuD, YuanJ, et al.l‐borneol promotes neurovascular unit protection in the subacute phase of transient middle cerebral artery occlusion rats: P 38‐MAPK pathway activation, anti‐inflammatory, and anti‐apoptotic effect. Phytother Res, 2023; 37(9):4166–4184.
54.
ZhuG, XiangT, LiangS, et al.Klotho gene might antagonize ischemic injury in stroke rats by reducing the expression of AQP4 via P38MAPK pathway. J Stroke Cerebrovasc Dis, 2023; 32(8):107205.
55.
XuR, BiY, HeX, et al.Kidney-tonifying blood-activating decoction delays ventricular remodeling in rats with chronic heart failure by regulating gut microbiota and metabolites and p38 mitogen-activated protein kinase/p65 nuclear factor kappa-B/aquaporin-4 signaling pathway. J Ethnopharmacol, 2024; 330:118110.
56.
LeandrouE, ChalatsaI, AnagnostouD, et al.α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3. 2 calcium signaling in astrocytes. Transl Neurodegener, 2024; 13(1):11.
57.
XuanT, WangD, LvJ, et al.Downregulation of Cypher induces apoptosis in cardiomyocytes via Akt/p38 MAPK signaling pathway. Int J Med Sci, 2020; 17(15):2328–2337.
58.
ZhuP, WuX, NiL, et al.Inhibition of PP2A ameliorates intervertebral disc degeneration by reducing annulus fibrosus cells apoptosis via p38/MAPK signal pathway. Biochim Biophys Acta Mol Basis Dis, 2024; 1870(1):166888.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
